Breast cancer subtype intertumor heterogeneity: MRI‐based features predict results of a genomic assay

Abstract

A model for IDC using imaging and pathology information correlates with Oncotype Dx RS scores, suggesting that image-based features could also predict the likelihood of recurrence and magnitude of chemotherapy benefit.